메뉴 건너뛰기




Volumn 176, Issue 3, 2014, Pages 1017-1020

Alternations of cardiac IK1 and Ito from FKBP12.6 transgenic mouse heart and potential impact of cardiac hypertrophy

Author keywords

Action potential; Cardiac hypertrophy; FKBP12.6; K+ channels; Ventricular cardiomyocyte

Indexed keywords

FK 506 BINDING PROTEIN; TACROLIMUS BINDING PROTEIN 1B; VOLTAGE GATED POTASSIUM CHANNEL;

EID: 84908216548     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2014.07.081     Document Type: Article
Times cited : (3)

References (12)
  • 1
    • 0028900536 scopus 로고
    • Immunophilins and the nervous system
    • S.H. Snyder, and D.M. Sabatini Immunophilins and the nervous system Nat Med 1 1 1995 32 37
    • (1995) Nat Med , vol.1 , Issue.1 , pp. 32-37
    • Snyder, S.H.1    Sabatini, D.M.2
  • 2
    • 77953812124 scopus 로고    scopus 로고
    • Kinetics of FKBP12.6 binding to ryanodine receptors in permeabilized cardiac myocytes and effects on Ca sparks
    • T. Guo, R.L. Cornea, and S. Huke Kinetics of FKBP12.6 binding to ryanodine receptors in permeabilized cardiac myocytes and effects on Ca sparks Circ Res 106 11 2010 1743 1752
    • (2010) Circ Res , vol.106 , Issue.11 , pp. 1743-1752
    • Guo, T.1    Cornea, R.L.2    Huke, S.3
  • 3
    • 0032576689 scopus 로고    scopus 로고
    • Cardiac defects and altered ryanodine receptor function in mice lacking FKBP12
    • W. Shou, B. Aghdasi, and D.L. Armstrong Cardiac defects and altered ryanodine receptor function in mice lacking FKBP12 Nature 391 6666 1998 489 492
    • (1998) Nature , vol.391 , Issue.6666 , pp. 489-492
    • Shou, W.1    Aghdasi, B.2    Armstrong, D.L.3
  • 4
    • 0037149508 scopus 로고    scopus 로고
    • Oestrogen protects FKBP12.6 null mice from cardiac hypertrophy
    • H.B. Xin, T. Senbonmatsu, and D.S. Cheng Oestrogen protects FKBP12.6 null mice from cardiac hypertrophy Nature 416 6878 2002 334 338
    • (2002) Nature , vol.416 , Issue.6878 , pp. 334-338
    • Xin, H.B.1    Senbonmatsu, T.2    Cheng, D.S.3
  • 5
    • 0031879342 scopus 로고    scopus 로고
    • FKBP12 is not required for the modulation of transforming growth factor beta receptor i signaling activity in embryonic fibroblasts and thymocytes
    • C.H. Bassing, W. Shou, S. Muir, J. Heitman, M.M. Matzuk, and X.F. Wang FKBP12 is not required for the modulation of transforming growth factor beta receptor I signaling activity in embryonic fibroblasts and thymocytes Cell Growth Differ 9 3 1998 223 228
    • (1998) Cell Growth Differ , vol.9 , Issue.3 , pp. 223-228
    • Bassing, C.H.1    Shou, W.2    Muir, S.3    Heitman, J.4    Matzuk, M.M.5    Wang, X.F.6
  • 6
    • 0037708928 scopus 로고    scopus 로고
    • FKBP12.6 deficiency and defective calcium release channel (ryanodine receptor) function linked to exercise-induced sudden cardiac death
    • X.H. Wehrens, S.E. Lehnart, and F. Huang FKBP12.6 deficiency and defective calcium release channel (ryanodine receptor) function linked to exercise-induced sudden cardiac death Cell 113 7 2003 829 840
    • (2003) Cell , vol.113 , Issue.7 , pp. 829-840
    • Wehrens, X.H.1    Lehnart, S.E.2    Huang, F.3
  • 7
    • 85027931141 scopus 로고    scopus 로고
    • FKBP12 is a critical regulator of the heart rhythm and the cardiac voltage-gated sodium current in mice
    • M. Maruyama, B.Y. Li, and H. Chen FKBP12 is a critical regulator of the heart rhythm and the cardiac voltage-gated sodium current in mice Circ Res 108 9 2011 1042 1052
    • (2011) Circ Res , vol.108 , Issue.9 , pp. 1042-1052
    • Maruyama, M.1    Li, B.Y.2    Chen, H.3
  • 8
    • 83055178342 scopus 로고    scopus 로고
    • Transgenic analysis of the role of FKBP12.6 in cardiac function and intracellular calcium release
    • Y. Liu, H. Chen, and G. Ji Transgenic analysis of the role of FKBP12.6 in cardiac function and intracellular calcium release Assay Drug Dev Technol 9 6 2011 620 627
    • (2011) Assay Drug Dev Technol , vol.9 , Issue.6 , pp. 620-627
    • Liu, Y.1    Chen, H.2    Ji, G.3
  • 10
    • 33644670611 scopus 로고    scopus 로고
    • Targeted deletion of Kv4.2 eliminates I(to, f) and results in electrical and molecular remodeling, with no evidence of ventricular hypertrophy or myocardial dysfunction
    • W. Guo, W.E. Jung, and C. Marionneau Targeted deletion of Kv4.2 eliminates I(to, f) and results in electrical and molecular remodeling, with no evidence of ventricular hypertrophy or myocardial dysfunction Circ Res 97 12 2005 1342 1350
    • (2005) Circ Res , vol.97 , Issue.12 , pp. 1342-1350
    • Guo, W.1    Jung, W.E.2    Marionneau, C.3
  • 11
    • 0037155771 scopus 로고    scopus 로고
    • Reduction of I(to) causes hypertrophy in neonatal rat ventricular myocytes
    • Z. Kassiri, C. Zobel, T.T. Nguyen, J.D. Molkentin, and P.H. Backx Reduction of I(to) causes hypertrophy in neonatal rat ventricular myocytes Circ Res 90 5 2002 578 585
    • (2002) Circ Res , vol.90 , Issue.5 , pp. 578-585
    • Kassiri, Z.1    Zobel, C.2    Nguyen, T.T.3    Molkentin, J.D.4    Backx, P.H.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.